190 related articles for article (PubMed ID: 26910582)
1. Differential antagonism and tolerance/cross-tolerance among nicotinic acetylcholine receptor agonists: scheduled-controlled responding and hypothermia in C57BL/6J mice.
de Moura FB; McMahon LR
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):240-8. PubMed ID: 26910582
[TBL] [Abstract][Full Text] [Related]
2. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
Cunningham CS; McMahon LR
Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
[TBL] [Abstract][Full Text] [Related]
3. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
4. Differential cross-tolerance to the effects of nicotinic acetylcholine receptor drugs in C57BL/6J mice following chronic varenicline.
de Moura FB; McMahon LR
Behav Pharmacol; 2019 Aug; 30(5):412-421. PubMed ID: 30398980
[TBL] [Abstract][Full Text] [Related]
5. Unexpected loss of sensitivity to the nicotinic acetylcholine receptor antagonist activity of mecamylamine and dihydro-β-erythroidine in nicotine-tolerant mice.
de Moura FB; Wilkerson JL; McMahon LR
Brain Behav; 2020 Apr; 10(4):e01581. PubMed ID: 32092237
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice.
Rodriguez JS; Cunningham CS; Moura FB; Ondachi P; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2014 Dec; 231(23):4455-66. PubMed ID: 24800895
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel Monkeys.
Withey SL; Doyle MR; Bergman J; Desai RI
J Pharmacol Exp Ther; 2018 Aug; 366(2):397-409. PubMed ID: 29784663
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
Cunningham CS; Javors MA; McMahon LR
J Pharmacol Exp Ther; 2012 Jun; 341(3):840-9. PubMed ID: 22438471
[TBL] [Abstract][Full Text] [Related]
9. The discriminative stimulus effects of epibatidine in C57BL/6J mice.
de Moura FB; Hiranita T; McMahon LR
Behav Pharmacol; 2020 Sep; 31(6):565-573. PubMed ID: 32209809
[TBL] [Abstract][Full Text] [Related]
10. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
11. Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
Cunningham CS; McMahon LR
Psychopharmacology (Berl); 2013 Jul; 228(2):321-33. PubMed ID: 23494230
[TBL] [Abstract][Full Text] [Related]
12. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
Ortiz NC; O'Neill HC; Marks MJ; Grady SR
Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
[TBL] [Abstract][Full Text] [Related]
13. Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats.
Liu X; Palmatier MI; Caggiula AR; Donny EC; Sved AF
Psychopharmacology (Berl); 2007 Nov; 194(4):463-73. PubMed ID: 17616849
[TBL] [Abstract][Full Text] [Related]
14. The discriminative stimulus effects of i.v. nicotine in rhesus monkeys: Pharmacokinetics and apparent pA
Moerke MJ; Zhu AZ; Tyndale RF; Javors MA; McMahon LR
Neuropharmacology; 2017 Apr; 116():9-17. PubMed ID: 27940077
[TBL] [Abstract][Full Text] [Related]
15. Nicotine-induced enhancement of responding for conditioned reinforcement in rats: role of prior nicotine exposure and α4β2 nicotinic receptors.
Guy EG; Fletcher PJ
Psychopharmacology (Berl); 2013 Jan; 225(2):429-40. PubMed ID: 22885874
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.
Freitas K; Carroll FI; Negus SS
Exp Clin Psychopharmacol; 2016 Feb; 24(1):65-75. PubMed ID: 26461167
[TBL] [Abstract][Full Text] [Related]
17. Nicotine Enhances the Hypnotic and Hypothermic Effects of Alcohol in the Mouse.
Slater CA; Jackson A; Muldoon PP; Dawson A; O'Brien M; Soll LG; Abdullah R; Carroll FI; Tapper AR; Miles MF; Banks ML; Bettinger JC; Damaj IM
Alcohol Clin Exp Res; 2016 Jan; 40(1):62-72. PubMed ID: 26727524
[TBL] [Abstract][Full Text] [Related]
18. Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.
Jutkiewicz EM; Rice KC; Carroll FI; Woods JH
Drug Alcohol Depend; 2013 Aug; 131(3):284-97. PubMed ID: 23333294
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.
Marks MJ; O'Neill HC; Wynalda-Camozzi KM; Ortiz NC; Simmons EE; Short CA; Butt CM; McIntosh JM; Grady SR
Neuropharmacology; 2015 Dec; 99():142-55. PubMed ID: 26192545
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic receptor antagonists as treatments for nicotine abuse.
Crooks PA; Bardo MT; Dwoskin LP
Adv Pharmacol; 2014; 69():513-51. PubMed ID: 24484986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
